Growth Metrics

Sangamo Therapeutics (SGMO) Non-cash Items (2016 - 2018)

Sangamo Therapeutics (SGMO) has disclosed Non-cash Items for 7 consecutive years, with $24.5 million as the latest value for Q4 2018.

  • For Q4 2018, Non-cash Items rose 530.44% year-over-year to $24.5 million; the TTM value through Dec 2018 reached $24.5 million, up 530.44%, while the annual FY2018 figure was $24.5 million, 530.44% up from the prior year.
  • Non-cash Items hit $24.5 million in Q4 2018 for Sangamo Therapeutics, up from $3.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $50.8 million in Q4 2014 and bottomed at $41000.0 in Q4 2016.
  • Average Non-cash Items over 5 years is $18.6 million, with a median of $14.1 million recorded in 2015.
  • Year-over-year, Non-cash Items tumbled 99.71% in 2016 and then surged 9366.04% in 2017.
  • Sangamo Therapeutics' Non-cash Items stood at $50.8 million in 2014, then plummeted by 72.28% to $14.1 million in 2015, then crashed by 99.71% to $41000.0 in 2016, then soared by 9366.04% to $3.9 million in 2017, then soared by 530.44% to $24.5 million in 2018.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $24.5 million, $3.9 million, and $41000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.